Mimedx Group Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.60

-0.09 (-2.44%)

As of May 9, 9:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +570.8% upside

Low Target $19.42

Average Target $24.15

High Target $35.38

Current Price $3.60

Current
$3.60

Target
$24.15

$19.42 $24.15 avg $35.38

Scenario Analysis

Bear Case

$19.42

439.4%

Low target

Base Case

$24.15

+570.8%

Avg target

Bull Case

$35.38

+882.8%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$7.99

-54.9% from high

52-Week Low

$3.03

+19.0% from low

Target vs 52W High

$24.15

+202.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%